Table 4 Publications on endoscopic resection for early oesophageal squamous cell carcinoma.
| First author, ref. | Patients (n) | Resection technique | Complications | Complete response | Follow‐up (months) | Recurrences/metachronous lesions |
|---|---|---|---|---|---|---|
| Takeshita47 | 56 (HGIN 9, MC 43, SMC 4) | ER‐C | Minor bleeding 3.6% | 100% | 39 | 0% |
| Stricture 3.6% | ||||||
| Perforation 1.8% | ||||||
| Giovannini48 | 14 | L&C | Minor bleeding 5% | 90.4% | 20 | 21.4% |
| Narahara49 | 21 | L&C | Minor bleeding 24% | 100% | 24 | 0% |
| Shimizu50 | 82 (74 MC, 8 SMC) | ER‐C, ER tube | n.a. | 100% | 25 | 17% (1 tumour‐related death) |
| Nomura51 | 51 | ER tube | n.a. | 100% | 18 | 8% |
| Shimizu52 | 26 (SMC) | n.a. | 0% | n.a. | 45 | 2 tumour‐related deaths |
| Pech53 | 39 (HGIN 10, MC 19, SMC 10) | ER‐L, ER‐C | Minor bleeding 7.5%, stricture 7.5% | 92% | 29.7 | 16.7% |
| Katada17 | 116 MC | L&C, ER‐C | n.a. | 100% | 35 | 20% |
| Fujishiro29 | 43 | ESD | Strictures 16%, perforation 6.9% | 100% | 17 | 2.3% |
| Pech54 | 65 (HGIN 12, MC 53) | ER‐L, ER‐C | Minor bleeding 3%, strictures 23% | 95.4% | 39.3 | 26% (2 tumour‐related deaths) |
APC, argon plasma coagulation; ER tube, endoscopic resection with a tube; ER‐C, endoscopic resection with cap device; ER‐L, endoscopic resection with ligation device; ESD, endoscopic submucosal dissection; HGIN, high‐grade intraepithelial neoplasia; L&C, lift and cut; LGIN, low‐grade intraepithelial neoplasia; MC, mucosal carcinoma; OP, surgery; PDT, photodynamic therapy; SMC, submucosal carcinoma.